Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DFV890 in Familial Cold Autoinflammatory Syndrome
NCT04868968Phase 2Completed
- Sponsor
- Novartis
- Start
- Sep 2021
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of DFV890 in familial cold autoinflammatory syndrome (FCAS), sponsored by Novartis. Started Sep 2021; status: completed.
02
Drugs
DFV890
03
Conditions
familial cold autoinflammatory syndrome (FCAS)
Beyond the preview
Go deeper on NCT04868968.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04868968.